Reducing Port Access Pain and Clinic Wait Time: An Evaluation of EMLA Cream Versus nüm™ Vapocoolant Spray

NCT06023368 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Administrative burden

Conditions

Pediatric Cancer

Interventions

DRUG: Num Vapocoolant Spray
DRUG: EMLA Cream

Sponsor

Marianne Hutti

Collaborators

[object Object]